Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Graceway Pharmaceuticals, LLC
Graceway Pharmaceuticals, LLC
Industry · 20 registered clinical trials.
Status
Trial
Phase
Started
Completed
Dose Ranging Study of Metronidazole Vaginal Gel in the Treatment of Bacterial Vaginosis
Vaginosis, Bacterial, Vaginal Infection
Phase 2
2010-01-01
Completed
Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery
Actinic Keratosis
Phase 3
2009-05-01
Completed
Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts
Genital Warts
Phase 3
2008-08-01
Completed
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
Genital Warts
Phase 3
2008-05-01
Completed
Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year
Actinic Keratoses
—
2008-04-01
Completed
Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)
Actinic Keratosis
Phase 3
2008-01-01
Completed
Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)
Actinic Keratoses
Phase 3
2008-01-01
Completed
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Keratosis
Phase 4
2005-06-01
Completed
A Study to Validate Cosmetic Outcome Scales Used to Rate Uneven Skin Color and Wrinkling
Skin Wrinkling
—
2005-06-01
Completed
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Ar
Keratosis
Phase 4
2005-05-01
Completed
An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Warts
Phase 2
2005-03-01
Completed
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Warts
Phase 2
2005-03-01
Completed
1-Year Follow up to the 1473-IMIQ Study
Keratosis
—
2005-01-01
Completed
Study With a Topical Gel to Treat Common Warts in Adults
Warts
Phase 2
2004-10-01
Completed
Study With a Topical Gel to Treat Common Warts in Adults
Warts
Phase 2
2004-08-01
Completed
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Warts
Phase 2
2004-04-01
Completed
Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults
Warts
Phase 2
2004-03-01
Completed
A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence
Basal Cell Carcinoma
Phase 3
2004-01-01
Completed
Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream
Actinic Keratosis
Phase 2
2003-01-01
Completed
Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream
Superficial Basal Cell Carcinoma
Phase 3
2001-03-01